Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-17 | New | $55,668,255 | $55,668,255 | Equity Only | 06b | SEC link |
| 2023-06-20 | New | $72,215,130 | $72,215,130 | Equity Only | 06b | SEC link |
| 2022-08-03 | New | $42,891,000 | $42,891,000 | Equity Only | 06b | SEC link |
| 2017-03-24 | New | $10,506,500 | $10,506,500 | Equity Only | 06b | SEC link |
| 2014-12-12 | New | $4,662,780 | $4,662,780 | Equity Only | 06b | SEC link |
| 2014-12-08 | New | $150,000,000 | $150,000,000 | Equity Only | 06b | SEC link |
| 2012-08-07 | New | $35,000,000 | $35,000,000 | Equity Only | 06 | SEC link |
| 2010-03-31 | New | $75,035,737 | $75,035,737 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Kristen L. Alexander | Executive |
| Phillipe J. Amouyal | Director |
| Philippe J. Amouyal | Director |
| Samuel Barker | Director |
| Philip M Brown | Executive |
| Ivan H. Cheung | Director |
| Lonnel Coats | Director, Executive |
| Scott Coiante | Executive |
| Brian T. Crum | Executive |
| Lisa De Francesco | Executive |
| Raymond Debbane | Director |
| Mike Exton | Director, Executive |
| Suma Gopinathan | Executive |
| Craig B. Granowitz | Executive |
| Kenneth B. Kassler Taub | Executive |
| Pablo Lapuerta | Executive |
| Robert J. Lefkowitz | Director |
| Alan J. Main | Executive |
| Rachel Martens | Executive |
| Wendy E. Mc Dermott | Executive |
| Alan S. Nies | Director |
| John Northcott | Executive |
| Frank P. Palantoni | Director |
| Arthur T. Sands | Director, Executive |
| Alexander Santini | Executive |
| Kiernan A. Seth | Executive |
| Christopher Sobecki | Director |
| Diane E. Sullivan | Director |
| Judith L. Swain | Director |
| James F. Tessmer | Executive |
| Steven A Tragash | Executive |
| Praveen Tyle | Executive |
| Jeffrey L. Wade | Executive |
| Brian P. Zambrowicz | Executive |